End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin’s lymphoma
Jeffrey A. BarnesCenter for Lymphoma, Massachusetts General Hospital Cancer CenterAnn S. LaCasceDepartment of Medicine, Harvard Medical SchoolKatherine ZukotynskiDepartment of Imaging, Dana-Farber Cancer Institute; Department of Radiology, Harvard Medical SchoolDavid IsraelDepartment of Imaging, Dana-Farber Cancer Institute; Department of Radiology, Harvard Medical SchoolYang FengDepartment of Biostatistics, Dana-Farber Cancer InstituteDonna NeubergDana-Farber/Harvard Cancer CenterChristiana E. ToomeyCenter for Lymphoma, Massachusetts General Hospital Cancer CenterEphraim P. HochbergCenter for Lymphoma, Massachusetts General Hospital Cancer CenterGeorge P. CanellosDepartment of Medical Oncology, Dana-Farber Cancer Institute; Department of Medicine, Harvard Medical SchoolJeremy S. AbramsonCenter for Lymphoma, Massachusetts General Hospital Cancer Center
2010en
Ochiq kirishBronza
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba